Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.050
0.00 (0.00%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $65.02 million as of August 7, 2026. Its market cap has decreased by -38.78% in one year.
Market Cap
65.02M
Enterprise Value
-77.09M
1-Year Change
-38.78%
Ranking
Category
Stock Price
$1.05
ChartMarket Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $65.02M, a decrease of -91.19%. That is a compound annual growth rate of -32.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 65.02M | -13.27% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 68.14M |
| Acrivon Therapeutics | 68.05M |
| Spero Therapeutics | 67.74M |
| MindWalk Holdings | 67.73M |
| Alps Group | 65.73M |
| MediciNova | 65.46M |
| Cingulate | 65.39M |
| Cardiff Oncology | 64.89M |